K. G. Alberti, R. H. Eckel, S. M. Grundy, P. Z. Zimmet, J. I. Cleeman et al., Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity, Circulation, vol.120, pp.1640-1645, 2009.

M. G. Saklayen, The global epidemic of the metabolic syndrome, Curr. Hypertens. Rep, vol.20, 2018.

B. Isomaa, P. Almgren, T. Tuomi, B. Forsen, K. Lahti et al., Cardiovascular morbidity and mortality associated with the metabolic syndrome, Diabetes Care, vol.24, pp.683-689, 2001.

M. P. Stern, K. Williams, C. Gonzalez-villalpando, K. J. Hunt, and S. M. Haffner, Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care, vol.27, pp.2676-2681, 2004.

J. Plumb, S. Pigat, F. Bompola, M. Cushen, H. Pinchen et al., Ebasis (bioactive substances in food information systems) and bioactive intakes: Major updates of the bioactive compound composition and beneficial bioeffects database and the development of a probabilistic model to assess intakes in europe, vol.9, 2017.

S. Grimsgaard, K. H. Bonaa, J. B. Hansen, and A. Nordoy, Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids, Am. J. Clin. Nutr, vol.66, pp.649-659, 1997.

Y. Qin, M. Xia, J. Ma, Y. Hao, J. Liu et al., Anthocyanin supplementation improves serum ldl-and hdl-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects, Am. J. Clin. Nutr, vol.90, pp.485-492, 2009.

B. Phongnarisorn, C. Orfila, M. Holmes, and J. L. Marshall, Enrichment of biscuits with matcha green tea powder: Its impact on consumer acceptability and acute metabolic response, vol.7, p.17, 2018.

K. G. Lenssen, A. Bast, and A. De-boer, Clarifying the health claim assessment procedure of efsa will benefit functional food innovation, J. Funct. Foods, vol.47, pp.386-396, 2018.

, Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contribution to the maintenance or achievement of a normal body weight (ID 629), brain, eye and nerve development (ID 627, 689, 704, 742, 3148, 3151), maintenance of normal brain function (ID 565, 626, 631, 689, 690, 704, 742, 3148, 3151), maintenance of normal vision (ID 627, 632, 743, 3149) and maintenance of normal spermatozoa motility, EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)

, Scientific Opinion on the substantiation of health claims related to beta glucans and maintenance of normal blood cholesterol concentrations (ID 754, 755, 757, 801, 1465, 2934) and maintenance or achievement of a normal body weight (ID 820, 823) pursuant to Article 13(1) of Regulation (EC) No 1924, EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), vol.7, p.1254, 2006.

S. Brandenburger and M. Birringer, European health claims for small and medium-sized companies-utopian dream or future reality? Funct. Foods Health D, vol.5, pp.44-56, 2015.

L. Brown, S. P. Caligiuri, D. Brown, and G. N. Pierce, Clinical trials using functional foods provide unique challenges, J. Funct. Foods, vol.45, pp.233-238, 2018.

S. Eldridge, C. Bond, M. Campbell, S. Hopewell, L. Thabane et al., Defining feasibility and pilot studies in preparation for randomised controlled trials: Using consensus methods and validation to develop a conceptual framework, Trials, vol.16, 2015.

C. Marsaux, S. Storcksdieck, P. Putz, C. Orfila, S. Sutulic et al., Scientific Guidelines for the Substantiation of Health Benefits from a (Bioactive-Enriched) Food, 2017.

A. Bordoni, C. Boesch, C. Malpuech-brugère, C. Orfila, and L. Tomás-cobos, The role of bioactives in energy metabolism and metabolic syndrome, Proc. Nutr. Soc, vol.10, pp.1-11, 2019.

S. Sutulic, M. J. Holmes, S. Garelli, M. Herrmann, S. Seifert et al., Dietary intake of food bioactives in a cohort of european adults with metabolic syndrome enrolled in the pathway-27 trial, Proc. Nutr. Soc, vol.77, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02062450

S. Sutulic, J. Amat, A. Blot, I. Nemeth, Z. Kertész et al., Protocol for pilot studies: effectiveness of bioactive enriched foods (bef) on markers of metabolic syndrome. White Rose Res, 2019.

, Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol, EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), vol.8, p.1461, 2010.

, Scientific Opinion on the substantiation of a health claim related to oat beta glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to article 14 of Regulation (EC) No 1924, EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), vol.8, p.1885, 2006.

, WHO. Waist Circumference and Waist-Hip Ratio Report of a WHO Expert Consultation, vol.WHO, pp.978-92, 2008.

J. Folch, M. Lees, and G. H. Sloane-stanley, A simple method for the isolation and purification of total lipides from animal tissues, J. Biol. Chem, vol.226, pp.497-509, 1957.

W. Stoffel, F. Chu, and E. H. Ahrens, Analysis of long-chain fatty acids by gas-liquid chromatography, Anal. Chem, vol.31, pp.307-308, 1959.

V. Ghini, M. Di-nunzio, L. Tenori, V. Valli, F. Danesi et al., Evidence of a DHA signature in the lipidome and metabolome of human hepatocytes, Int. J. Mol. Sci, vol.18, p.359, 2017.

C. Lotti, J. Rubert, F. Fava, K. Tuohy, F. Mattivi et al., Development of a fast and cost-effective gas chromatography-mass spectrometry method for the quantification of short-chain and medium-chain fatty acids in human biofluids, Anal. Bioanal. Chem, vol.409, pp.5555-5567, 2017.

M. Gasperotti, D. Masuero, G. Guella, F. Mattivi, and U. Vrhovsek, Development of a targeted method for twenty-three metabolites related to polyphenol gut microbial metabolism in biological samples, using spe and uhplc-esi-ms/ms, Talanta, vol.128, pp.221-230, 2014.

C. Ancillotti, M. Ulaszewska, F. Mattivi, and M. Del-bubba, Untargeted metabolomics analytical strategy based on liquid chromatography/electrospray ionization linear ion trap quadrupole/orbitrap mass spectrometry for discovering new polyphenol metabolites in human biofluids after acute ingestion of vaccinium myrtillus berry supplement, J. Am. Soc. Mass Spectrom, vol.30, pp.381-402, 2019.

C. A. Watters, C. M. Edmonds, L. S. Rosner, and K. P. Sloss, A cost analysis of epa and dha in fish, supplements, and foods, Nutr. Food Sci, vol.2012, pp.159-163

J. J. Carrero, L. Baró, J. Fonollá, M. González-santiago, A. Martínez-férez et al., López-Huertas, E. Cardiovascular effects of milk enriched with ?-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins e and b6 in volunteers with mild hyperlipidemia, Nutrition, vol.20, pp.521-527, 2004.

C. Dawczynski, L. Martin, A. Wagner, and G. Jahreis, N-3 lc-pufa-enriched dairy products are able to reduce cardiovascular risk factors: A double-blind, cross-over study, Clin. Nutr, vol.29, pp.592-599, 2010.

A. Goncalves, M. Margier, C. Tagliaferri, P. Lebecque, S. George et al., Pinoresinol of olive oil decreases vitamin d intestinal absorption, Food Chem, vol.206, pp.234-238, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01478510

E. Reboul, S. Thap, E. Perrot, M. J. Amiot, D. Lairon et al., Effect of the main dietary antioxidants (carotenoids, gamma-tocopherol, polyphenols, and vitamin c) on alpha-tocopherol absorption, Eur. J. Clin. Nutr, vol.61, pp.1167-1173, 2007.

T. Y. Chen, M. G. Ferruzzi, Q. L. Wu, J. E. Simon, S. T. Talcott et al., Influence of diabetes on plasma pharmacokinetics and brain bioavailability of grape polyphenols and their phase ii metabolites in the zucker diabetic fatty rat, Mol. Nutr. Food Res, vol.61, 2017.

S. Karakaya, S. Simsek, A. T. Eker, C. Pineda-vadillo, D. Dupont et al., Stability and bioaccessibility of anthocyanins in bakery products enriched with anthocyanins, Food Funct, vol.7, pp.3488-3496, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01454640

C. Pineda-vadillo, F. Nau, C. G. Dubiard, V. Cheynier, E. Meudec et al., In vitro digestion of dairy and egg products enriched with grape extracts: Effect of the food matrix on polyphenol bioaccessibility and antioxidant activity, Food Res. Int, vol.88, pp.284-292, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01454599

P. C. Calder, Mechanisms of action of (n-3) fatty acids, J. Nutr, vol.142, pp.592-599, 2012.

C. Bjork, U. Wilhelm, S. Mandrup, B. D. Larsen, A. Bordoni et al., Effects of selected bioactive food compounds on human white adipocyte function, Nutr. Metab, vol.13, 2016.

X. Wei, D. Wang, Y. Yang, M. Xia, D. Li et al., Cyanidin-3-o-beta-glucoside improves obesity and triglyceride metabolism in kk-ay mice by regulating lipoprotein lipase activity, J. Sci. Food Agric, vol.91, pp.1006-1013, 2011.

P. Surampudi, B. Enkhmaa, E. Anuurad, and L. Berglund, Lipid lowering with soluble dietary fiber, Curr. Atheroscler. Rep, vol.18, 2016.

P. Gunness, J. Michiels, L. Vanhaecke, S. De-smet, O. Kravchuk et al., Reduction in circulating bile acid and restricted diffusion across the intestinal epithelium are associated with a decrease in blood cholesterol in the presence of oat beta-glucan, FASEB J, vol.30, pp.4227-4238, 2016.

M. Jayachandran, J. Chen, S. S. Chung, and B. Xu, A critical review on the impacts of beta-glucans on gut microbiota and human health, J. Nutr. Biochem, vol.61, pp.101-110, 2018.

F. A. Tomas-barberan, M. V. Selma, and J. C. Espin, Interactions of gut microbiota with dietary polyphenols and consequences to human health, Curr. Opin. Clin. Nutr. Metab. Care, vol.19, pp.471-476, 2016.

R. Garcia-villalba, H. Vissenaekens, J. Pitart, M. Romo-vaquero, J. C. Espin et al., Gastrointestinal simulation model twin-shime shows differences between human urolithin-metabotypes in gut microbiota composition, pomegranate polyphenol metabolism, and transport along the intestinal tract, J. Agric. Food Chem, vol.65, pp.5480-5493, 2017.